Match evidence to the actual format
FDA identifies safety information gaps and peptide-characterization concerns for BPC-157. A vial and spray under the same compound name are different preparations; neither is verified by the other's paperwork.
Documentation to request
Compare the exact formulation, total content and analytical methods separately for each format. A listed purity number alone would not establish sterility or clinical suitability.
Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Evidence review before expanding a clinic menu. These references support a review, not a treatment recommendation or supply authorization.